Pfizer quarterly revenue soars 19.7 percent
May 03, 2016 at 06:54 AM EDT
(Reuters) - U.S. drugmaker Pfizer Inc reported a 19.7 percent rise in quarterly revenue, boosted by sales of its new treatments for cancer and its Hospira acquisition.
